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ABSTRACT
Background: Allergic manifestation in ear is a common unrecognized otologic disorder worldwide. This 
study aimed at determining the clinicoepidemiologic pattern and management of patients with allergic ear 
disorder.
Materials and Methods: This was a prospective hospital-based study of patients with clinical diagnosis 
of allergic ear disorder. Interviewer assisted questionnaire were administered to the consented patient. Data 
obtained were collated and analyzed using SPSS statistical software version 18.0.
Results: Prevalence of allergic ear disorder in this study was 4.2%. There was 59.8% male with male to 
female ratio of 1.5:1. No allergen was identified in 7.3%. Common self-reported trigger factor were dirty/
earwax, water/Soap and eardrop/body cream in 72.0%, 53.7% and 39.0% respectively. There was family his-
tory of allergy in 58.5% of respondents. Common symptoms were pinna pulling/ear picking, ear blockage, 
hearing impairment and itchy ear in 81.7%, 56.7%, 54.3% and 49.4% respectively. A commonest finding on 
examination was clean external ear canal 81.7%. Middle ear cleft was the commonest affected part of the ear 
in 56.7%. A commonest associated comorbid illness was 64.6% allergic rhinitis. Commonest complication 
recorded was otitis media with effusion in 42.1% respondents. Main quality of life affected were sleep dis-
turbance, depression, changes in mood and general health in 43.9%, 31.7%, 26.8% and 25.6% respectively. 
Commonest treatment was conservative treatment in 86.6%.
Conclusion: Allergic ear disorder is a common ear, nose and throat disorder affecting all ages. At presen-
tation most cases were associated with comorbid illnesses, complications and impact on quality of life.  Early 
identification and referral of patient to a specialist and prompt treatment to reduce avoidable morbidity is 
advocated. (Int J Biomed Sci 2020; 16 (1): 5-10)
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BACKGROUND
Allergic affectation of ear is a common otologic disor-
der in otorhinolaryngological practice. It is an IgE-antigen 
and mast cell mediated hypersensitivity reaction of the ear 
lining reaction to the allergens. It is usually insidious in 
onset which when left untreated may affects the quality of 
life of the sufferer (1, 2).
Allergy is a global public health problem with various 
prevalence of up 20% to 40% worldwide and the trend is 
known to be on increase (3-5). Prevalence of allergy was 
found to be 44% in Singaporean school children (6, 7). In 
UK allergy affects up to 30% of adults and 40% of chil-
dren at some time in their lives (6, 7). In developing coun-
tries like Nigeria prevalence of allergy is not known. 
Allergy usually presented with symptoms which may 
either be perennial or seasonal (8). This depends on the 
kind of allergen that are responsible for the presenting 
symptoms (9,10). Allergic disorder is a chronic multi or-
gan disorder which involves inflammation of the mucous 
membranes of the ear, nose, sinuses, pharynx, larynx, 
bronchus and eyes in addition to the skin. The allergens 
include house dust mites, pollen, cat, dog, and molds (11). 
In early phase response the reaction occur in minutes 
also called immediate phase response while late phase re-
sponse occur over 4-8 hours and may persist for hours or 
days (12-15). 
Comorbid illnesses of allergic diseases have been well 
described in the populations (16,17). Allergic ear disorder 
may impact on patient health-related quality of life. Poorly 
controlled symptoms of allergic ear disorder may contrib-
ute to learning impairment, decreased overall cognitive 
functioning and decreased long-term productivity (18,19). 
In African, epidemiological data are scarce but the over-
all prevalence of allergy in children is at least 20% to 24% 
and there is evidence of increasing prevalence (20-22). This 
study aimed at determining the clinic-epidemiologic profile 
and management of allergic ear disorder among patients at-
tending Ekiti state university teaching hospital.
MATERIAL AND METHODS
This was a prospective hospital-based study of patients 
with clinical diagnosis of allergic ear disorder carried out 
at ear, nose and throat department of Ekiti state university 
teaching hospital. The study was carried out over a period 
of 2 years from May 2016 to April 2018.
Informed consent was obtained from patient/guardian/
parent before patients were enrolled into the study. 
Interviewer assisted questionnaire were given to the 
consented patient to obtained information on sociodemo-
graphic features and presenting ear complaints such itch-
ing, ear blockage, discharge, hearing impairment and ver-
tigo. Further information on duration, trigger factors and 
time on allergic ear disorder were also collected. Detailed 
otorhinolaryngological history was taken from the patient/
guardian/parents. Additional history on possible comor-
bid illnesses, complication and predisposing factor was 
taken. Past medical, surgical, family and social history 
were taken. General physical and systemic examination 
was performed. Thorough nose, ear, throat, head and neck 
examination were done and findings were documented. 
Otological examination as in otoscopy and nasal anterior 
and posterior rhinoscopy was performed.
All the patients were educated based on the findings 
and on the line of management of ear allergic. Patient were 
then managed conservatively, medically or combined. Pa-
tients were followed up in the ear, nose and throat clinic 
for three months. 
All data obtained were documented, collated and ana-
lyzed by using SPSS version 18.0. The analyzed data were 
expressed by simple descriptive methods with frequency 
tables, percentage, bar chart and pie chart.
Limitation to this study was diagnosis was made clini-
cally and no allergic tests were done. No instrument was 
used to obtain data on quality of life.
Ethical approval was considered and obtained from the 
ethical committee of the hospital.
RESULTS
During the study period, a total of 3916 patients were 
seen in ear, nose and throat department. Of these, 164 pa-
tients had clinical diagnosis of allergic ear disorder.  Thus, 
the prevalence of allergic ear disorder in this studied popu-
lation represents 4.2%. All the studied age group had aller-
gic ear disorder. The modal age group was 1-10 years and 
accounted for 49 (29.9%) of patients. This is demonstrated 
in Figure 1. 
There was male 98 (59.8%) preponderance over female 
66 (40.2%). Male to female ratio was 1.5:1. Majority of the 
patients 148 (90.2%) practices Christianity while 14 (8.5%) 
were Muslim. No formal and tertiary education level were 
the commonest educational distribution in 41 (25.0%) and 
36 (22.0%) respectively. Other educational levels were 
primary in 31 (18.9%) and preschool in 29 (17.7%). There 
were 43 (26.2%) students/apprentice, 28 (17.1%) farmers, 
26 (15.9%) business and 24 (14.6%) applicants constituted 
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the majority of the affected occupation group. Others were 
teachers in 22 (13.4%) and health workers in 21 (12.8%). 
Seventy four (45.1%) of the respondents were single while 
43 (26.2%) were married. Others were widow and di-
vorced in 28 (17.7%) and 19 (11.6%) respectively. This is 
illustrated in Table 1. 
No allergen was identified in 12 (7.3%) respondents. 
Common self reported trigger factor were dirty/earwax, 
water/Soap and eardrop/body cream in 118 (72.0%), 88 
(53.7%) and 64 (39.0%) respectively. Other self identify al-
lergens (triggers) were 46 (28.0%) sea/other food. There 
was family history of allergy in 96 (58.5%) compared to 
absence of family history of allergy in 68 (41.5%). This is 
demonstrated in Table 2. Common ear symptoms in this 
study were pinna pulling/ear picking, ear blockage, hear-
ing impairment and itchy ear in 132 (81.7%), 93 (56.7%), 89 
(54.3%) and 81 (49.4%) respectively. Other less common 
ear symptoms were vertigo in 3 (1.8%) and water sensation 
in the ear in 64 (39.0%). This is illustrated in Table 3.
A commonest associated comorbid illness was 106 
(64.6%) allergic rhinitis. Others were adenotonsillar dis-
orders, allergic conjunctivitis and asthma in 74 (45.1%), 47 
(28.7%) and 27 (16.5%) respectively. This is illustrated in 
Figure 2. In this study, associated complications were 69 
(42.1%) otitis media with effusion, 48 (23.9%) ear foreign 
body impaction, 42 (25.6%) ear injury and 36 (22.0%) oti-
tis external. Others were meniere’s disease in 2 (1.2%) and 
















Pre school 29 17.7
Primary education 31 18.9
Secondary education 27 16.4













Table 2. Allergic features among the patients




Eardrop/body cream 64 39.0
Sea/other food 46 28.0





aSome of the patients have more than one trigger factors.
Figure 1. Showing age group of respondents.
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Majority of the studied patients admitted interference 
with their daily activities. Main quality of life affected in-
cludes sleep disturbance, depression, changes in mood and 
general health which were responsible for 72 (43.9%), 52 
(31.7%), 44 (26.8%) and 42 (25.6%) respectively. Less af-
fected quality of life in this study was 29 (17.7%) psycho-
logical disorders and 31 (18.9%) anxiety. 
In this study, commonest form of treatment was con-
servative treatment in 142 (86.6%). Other offered treat-
ment were foreign body removal, ear syringing and aural 
toileting/dressing in 48 (29.3%), 42 (25.6%) and 33 (20.1%) 
respectively. All the procedures were done in the outpa-
tient clinic. No mortality was recorded in this study popu-
lation. This is showed in Figure 3. 
DISCUSSION
Allergic ear disorder is one of the major health prob-
lems in otorhinolaryngological practice and this affecting 
all ages worldwide. This has been demonstrated in this 
study. It has also been documented as a global health chal-
lenges (23, 24). In this hospital based study prevalence of 
ear allergy was found to be 4.2%. This is a lower prev-
alence compare to recorded prevalence in other allergic 
study.23,24 Low prevalence of allergic ear disorder findings 
in this study is because majority of patients result to self-
medication, herb medication or  treated in the peripheral 
hospitals. Only few complicated cases or those with co-
morbid illnesses are referred to or present to otorhinolar-
yngologist. Higher prevalence of allergy have been report-
ed in developed and industrial countries and some part of 
African countries (24, 25). 
Majority of patients with allergic ear disorder in this 
study were children. This may be due to increased number 
of children with allergy had associated comorbid illnesses 
and complications. This situation usually compelled par-
ents to seek medical intervention. The allergic ear disor-
der in adult are commonly ignored due to ignorant, mild 
symptoms and uncommon associated upper respiratory 
tract complications. The findings in this study is different 
from the record of previous study (26, 27). 
There was male preponderance in this study. A similar 
finding was reported in other study on allergic disorder 
(28). This finding is contrary to other studies on allergy 
which reported female predominance (29). Other study of 
allergic disorder also revealed no gender predilection in 
their findings (30). Majority of the patients reported feel-
ing of objects in the ear which leads to itchy ear from bath 
water/soap in the ear. Other findings also revealed ear ir-
ritation simultaneously in nose, throat and eye reaction to 
Table 3. Symptoms among the patients
Symptoms Frequency (n) Percentage (%)
Itchy ear 81 49.4
Ear blockage 93 56.7
Hearing impairment 89 54.3
Water sensation in ear 64 39.0
Vertigo 3 1.8
Pinna pulling/ear picking 132 80.5
Others 31 18.9
Some patients have more than one symptoms.
Figure 2. Comorbid illnesses among the respondents.
Figure 3. Types of management among the patients.
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allergens such as dust, cream, food and eardrop. A similar 
finding was reported in other study (18). 
Allergies are generally due to genetic predisposition 
and it is responsible for patients to develop allergic ear 
disorder. There is family history of allergy in our patient 
in various combinations of asthma, allergic rhinitis and 
conjuctivitis in most of our study patients. These findings 
were in agreement with other studies on allergy (31-33). 
In this study, majority of the patients presented with as-
sociated comorbid illnesses like asthma, eczema, sinusitis, 
conjunctivitis and adenotonsillar disorder. Some studies 
on allergy reported low incidence of associated comorbid 
illnesses in their findings (34, 35). Probably because of 
good environmental control, different genetic component, 
prompt treatment and early medical intervention of aller-
gic disorder. 
Complications in allergic ear disorder occur from poor-
ly controlled, non-treated long standing allergy or when it 
is associated with superimposed infection (viral, bacterial 
or fungal). This leads to the development of other disease 
such as otitis media, otitis media with effusion, hearing 
impairment, orbital complications, sinusitis, nasal polyps, 
abnormal craniofacial development and obstructive sleep 
apnea (36). Affected quality of life in the studied patients 
includes: disrupt sleep, interference with daily activities, 
psychological disorders, social dysfunction, changes in 
mood, depression, anxiety, fatigue, and sexual dysfunc-
tion. This observation was also noted in other allergic 
study (37).
Management of allergic ear disorder may require mul-
tidisciplinary approach for effective treatment outcome. 
This is because of associated comorbid illnesses, com-
plications and impact on quality of life. The specialist 
management team includes otorhinolaryngologists, radi-
ologist, paediatricians, psychiatrist, family physician and 
allergists (38). The treatment of allergy consists of aller-
gen avoidance (aggressive environmental control) which 
is effective but practically difficult (38). In addition to this; 
medical treatment using steroids and antihistamines are 
also administered. Surgical therapy is reserved for com-
plicated and comorbid illnesses. Conservative treatment 
in this study was done on all symptomatic patients using 
avoidance of allergens with antihistamines and steroid na-
sal spray which temporarily relief patient symptoms. This 
therapy is in line with treatment in other study (38). Ma-
jority of the patients had clinic minor procedure because 
of associated complications and comorbid illnesses. This 
finding was similar to the observation in other study (39). 
It is paramount for patients to know that all these treat-
ment cannot cure allergic ear disorder. This is a major 
concerned to patient/guardian/parent. In this study all pa-
tient noticed improvement at first week follow up visit. No 
death was recorded in this study on account of allergic ear 
disorder.
Allergic ear disorder is a common otologic disorder 
with under presentation among patients seen by Otorhino-
laryngologist. Many patients had associated comorbid ill-
nesses, complications and impact quality of life. Many of 
the patients were conservatively managed by emphasis on 
avoidance of triggers factor, prompt presentation and early 
referral to the Otorhinolaryngologist to avoid on toward 
outcome. It is therefore recommended that public enlight-
enment, further local and national study on allergic ear 
disorder in Nigeria is necessary.
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